# NKG7

## Overview
NKG7 is a gene that encodes the natural killer cell granule protein 7, a type-I integral membrane protein predominantly expressed in immune cells such as CD8+ T cells and natural killer (NK) cells. This protein is integral to the immune response, playing a critical role in the formation and function of immune synapses, which are essential for the targeted destruction of tumor cells. NKG7 is involved in the trafficking and release of cytolytic granules, which contain perforin and granzymes necessary for inducing apoptosis in target cells. The protein's structure includes four membrane-spanning domains, similar to the gamma subunit of an L-type voltage-gated calcium channel, indicating its involvement in calcium-dependent processes (Wen2021NKG7). NKG7 also regulates cytokine production, helping to modulate immune responses and prevent excessive inflammation (Lelliott2022NKG7). Alterations in NKG7 expression have significant clinical implications, particularly in cancer immunotherapy, where its expression levels can influence the efficacy of treatments such as anti-PD-1 therapy (Wen2021NKG7).

## Structure
The NKG7 protein is predicted to be a type-I integral membrane protein with a hydrophobic NH2 terminus and a signal sequence cleavage site between amino acids 22 and 23. The mature NKG7 peptide has a molecular weight of 13,400 kD and consists of a 38-amino acid external domain and a 64-amino acid cytoplasmic domain (Turman1993Characterization). The extracellular domain lacks N-glycosylation sites or cysteine residues but contains six segments with sequence characteristics commonly found in T-cell epitopes, suggesting potential interaction with MHC molecules (Turman1993Characterization). The intracellular domain includes potential phosphorylation sites, notably two protein-kinase-C phosphorylation sites at threonine residues 89 and 122 (Turman1993Characterization).

Structurally, NKG7 has four membrane-spanning domains that are similar to the gamma subunit of an L-type voltage-gated calcium channel, indicating a role in calcium-dependent processes (Wen2021NKG7). The protein is not homologous with any previously reported genes or peptides, suggesting it is a novel protein (Turman1993Characterization). Specific details about secondary, tertiary, or quaternary structures are not provided in the available context.

## Function
The NKG7 gene encodes a protein that plays a crucial role in the immune response, particularly in CD8+ T cells and natural killer (NK) cells. In healthy human cells, NKG7 is involved in the formation and efficiency of immune synapses, which are critical for the effective targeting and destruction of tumor cells. NKG7 enhances the cytotoxic activity of CD8+ T cells by facilitating efficient immune synapse formation, allowing these cells to kill multiple target cells in succession (Lelliott2022NKG7). 

NKG7 is associated with cytolytic granules in T cells and is essential for the proper trafficking and release of these granules, which contain perforin and granzymes necessary for inducing target cell death. The protein colocalizes with LAMP1 during granule exocytosis, and its absence leads to reduced degranulation and cytotoxicity (Wen2021NKG7). NKG7 also plays a role in regulating calcium flux within T cells, which is crucial for granule exocytosis and cytotoxic function (Wen2021NKG7). 

In addition to its role in cytotoxicity, NKG7 is involved in regulating cytokine production during immune responses, helping to limit excessive inflammation (Lelliott2022NKG7).

## Clinical Significance
Alterations in the expression of the NKG7 gene have significant clinical implications, particularly in the context of cancer immunotherapy. Reduced expression of NKG7 in CD8+ T cells is associated with decreased cytotoxic function, which can lead to poor responses to anti-PD-1 therapy in cancer patients. This reduction in NKG7 expression is linked to fewer cytolytic granules and impaired granule trafficking, resulting in diminished tumor cell killing (Wen2021NKG7). In nonresponders to anti-PD-1 therapy, CD8+ T cells exhibit lower NKG7 expression, which correlates with reduced antitumor activity and treatment efficacy (Wen2021NKG7).

NKG7 expression is also implicated in immune regulation and inflammation. Deficiency in NKG7 leads to prolonged immune synapse formation and hypersecretion of cytokines, which can exacerbate inflammatory responses. This suggests that NKG7 plays a role in modulating immune-mediated inflammation, potentially through pathways like JAK-STAT signaling (Lelliott2022NKG7).

Therapeutic strategies targeting NKG7, such as mRNA transfection to enhance its expression, have been proposed to improve the cytotoxic function of T cells in cancer patients, particularly those who do not respond to existing checkpoint blockade therapies (Wen2021NKG7).

## Interactions
NKG7, also known as natural killer cell granule protein 7, is involved in several interactions that are crucial for its role in immune responses. It is associated with cytolytic granules in T cells and interacts with proteins such as LAMP1 (CD107a) and perforin, which are involved in the cytotoxic function of T cells. This interaction is important for the effective killing of tumor cells by CD8+ T cells, as evidenced by colocalization studies using high-resolution confocal microscopy (Wen2021NKG7).

NKG7 is also implicated in regulating calcium release from lysosomal vesicles, which affects cytolytic granule trafficking and release within cytotoxic CD8+ T cells. This regulation is crucial for the cytotoxic activity of these cells, as NKG7 is structurally similar to the g subunit of an L-type voltage-gated calcium channel, suggesting its involvement in calcium-dependent processes (Wen2021NKG7).

Additionally, NKG7 is part of the gene signature in Th1 and cytotoxic cells, with the transcription factor T-bet binding to its promoter. This indicates a regulatory interaction at the transcriptional level, influencing NKG7 expression and, consequently, its role in immune responses (Na2024The).


## References


[1. (Wen2021NKG7) Ti Wen, Whitney Barham, Ying Li, Henan Zhang, Joanina K. Gicobi, Jacob B. Hirdler, Xin Liu, Hyoungjun Ham, Kodi E. Peterson Martinez, Fabrice Lucien, Roxane R. Lavoie, Hu Li, Cristina Correia, Dileep D. Monie, Zesheng An, Susan M. Harrington, Xiaosheng Wu, Ruifeng Guo, Roxana S. Dronca, Aaron S. Mansfield, Yiyi Yan, Svetomir N. Markovic, Sean S. Park, Jie Sun, Hong Qin, Minetta C. Liu, George Vasmatzis, Daniel D. Billadeau, and Haidong Dong. Nkg7 is a t-cell–intrinsic therapeutic target for improving antitumor cytotoxicity and cancer immunotherapy. Cancer Immunology Research, 10(2):162–181, December 2021. URL: http://dx.doi.org/10.1158/2326-6066.CIR-21-0539, doi:10.1158/2326-6066.cir-21-0539. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1158/2326-6066.CIR-21-0539)

[2. (Turman1993Characterization) Martin A. Turman, Toshio Yabe, Cynthia McSherry, Fritz H. Bach, and Jeffrey P. Houchins. Characterization of a novel gene (nkg7) on human chromosome 19 that is expressed in natural killer cells and t cells. Human Immunology, 36(1):34–40, January 1993. URL: http://dx.doi.org/10.1016/0198-8859(93)90006-m, doi:10.1016/0198-8859(93)90006-m. This article has 51 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/0198-8859(93)90006-m)

[3. (Lelliott2022NKG7) Emily J. Lelliott, Kelly M. Ramsbottom, Mark R. Dowling, Carolyn Shembrey, Tahereh Noori, Conor J. Kearney, Jessica Michie, Ian A. Parish, Margaret A. Jordan, Alan G. Baxter, Neil D. Young, Amelia J. Brennan, and Jane Oliaro. Nkg7 enhances cd8+ t cell synapse efficiency to limit inflammation. Frontiers in Immunology, July 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.931630, doi:10.3389/fimmu.2022.931630. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.931630)

[4. (Na2024The) Jinrui Na and Christian Engwerda. The role of cd4+ t cells in visceral leishmaniasis; new and emerging roles for nkg7 and tgfβ. Frontiers in Cellular and Infection Microbiology, May 2024. URL: http://dx.doi.org/10.3389/fcimb.2024.1414493, doi:10.3389/fcimb.2024.1414493. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcimb.2024.1414493)